<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04126434</url>
  </required_header>
  <id_info>
    <org_study_id>WeiHuang19</org_study_id>
    <nct_id>NCT04126434</nct_id>
  </id_info>
  <brief_title>Intervention of Air Pollution and Acute Coronary Syndrome</brief_title>
  <official_title>Intervention of Air Pollution and Acute Coronary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effect of intervention of ambient air pollution on acute coronary syndrome
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investgate the effect of wearing facemasks to decreasing levels of exposure to ambient air
      on acute coronary syndrome patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 10, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vascular function</measure>
    <time_frame>six months</time_frame>
    <description>Systolic blood pressure and diastolic blood pressure measured by omron HBP-1300</description>
  </primary_outcome>
  <primary_outcome>
    <measure>autonomic nervous function</measure>
    <time_frame>six months</time_frame>
    <description>Twenty four-hour electrocardiograms and heart rate variability</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>no masking</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>not wearing facemask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>masking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>wearing facemask</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>mask</intervention_name>
    <description>facemask</description>
    <arm_group_label>masking</arm_group_label>
    <arm_group_label>no masking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Non-smoker of any type during past six months and living in a non-smoking household.

          2. A diagnosis of myocardial infarction or unstable angina 7-90 days prior to signed
             informed consent.

        Exclusion Criteria:

          1. Unstable CV disorders including uncompensated heart failure, refractory angina,
             uncontrolled arrhythmias, critical valvular heart disease and severe hypertension.

          2. A history of infection with human immunodeficiency virus.

          3. History of malignancy including leukemia and lymphoma AND/OR any severe,
             life-threatening disease AND/OR history of drug abuse within the last 2 years.

          4. Pregnancy or intent to get pregnant during the study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Huang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Health Science Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wei Huang, PhD</last_name>
    <phone>+86-13521966787</phone>
    <email>whuang@bjmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University ,School of Public Health</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Huang, PHD</last_name>
      <phone>+86-13521966787</phone>
      <email>whuang@bjmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Wei Huang, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>October 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2019</study_first_posted>
  <last_update_submitted>October 15, 2019</last_update_submitted>
  <last_update_submitted_qc>October 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University</investigator_affiliation>
    <investigator_full_name>WeiHuang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

